Clinical trials: Acute Myeloid Leukemia With KMT2A Rearrangement

Acute Myeloid Leukemia

Pinometostat With Standard Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and MLL Gene Rearrangement

• Terminated
• Age: 14 years and older
• Phase 1/2
• Results posted

This phase Ib/II trial studies the side effects and best dose of pinometostat and how well it works with standard chemotherapy in treating patients with newly diagnosed acute myeloid leukemia and a type of genetic mutation called…

Trial name

NCT03724084

Testing

Cytarabine, Daunorubicin, Daunorubicin Hydrochloride

Where

3 sites in United States

Volunteers

6 people

Sponsor

National Cancer Institute (NCI)